WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael John SumnerChief Medical Officer2026-03-311,223$1.74
$2.13kSell
Jacqueline Elizabeth SheaChief Executive Officer2026-02-2613,657$1.79
$24.45kSell
Laurent HumeauChief Scientific Officer2026-02-262,064$1.79
$3.69kSell
Michael John SumnerChief Medical Officer2026-02-263,903$1.79
$6.99kSell
Peter KiesCFO2026-02-262,965$1.79
$5.31kSell
Peter KiesCFO2026-02-266,294$1.79
$11.27kSell
Jacqueline Elizabeth SheaChief Executive Officer2026-02-268,057$1.79
$14.42kSell
Laurent HumeauChief Scientific Officer2026-02-263,034$1.79
$5.43kSell
Laurent HumeauChief Scientific Officer2025-05-151,708$1.95
$3.33kSell
Peter KiesCFO2025-05-152,566$1.95
$5.00kSell

1 of 2

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe29.89%20,650,987$23.75MInsider
Fmr LLC14.25%9,846,664$11.32MInstitution
Tee Khiang Ng7.09%4,899,931$5.63MInsider
Vanguard Group Inc4.80%3,315,580$3.81MInstitution
Janus Henderson Group PLC4.79%3,308,406$3.80MInstitution
Adage Capital Partners GP LLC3.70%2,553,571$2.94MInstitution
Boxer Capital Management LLC3.50%2,420,122$2.78MInstitution
Jong Joseph Kim3.40%2,346,000$2.70MInsider
D E Shaw Co Inc3.23%2,231,811$2.57MInstitution
Adar1 Capital Management LLC2.15%1,485,008$1.71MInstitution

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO47.80%45.03%Net SellingNet Selling
QTTB28.18%71.82%Net SellingNet Selling
GOSS80.46%15.03%Net Buying
GANX19.08%3.09%
PTHS13.55%86.45%Net BuyingNet Selling
View Top Biotech Stocks

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 47.80% institutional shareholders, 45.03% Inovio Pharmaceuticals insiders, and 7.17% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 29.89% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $24.16M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.